Table 5 The binary logistic regression analysis results of the dual interaction of chronic diseases on the occurrence of depression in middle-aged and elderly individuals.

From: CHARLS insights into the impact of dual interactions of chronic diseases on depression in middle-aged and elderly individuals

Disease interaction variables

Beta

P-value

OR

95% CI

Diabetes-Hypertension

0.360

 < 0.001

1.433***

1.191–1.725

Diabetes-Apoplexy

1.225

 < 0.001

3.403***

2.013–5.755

Diabetes-Memory disorders

0.882

0.008

2.417**

1.254–4.657

Diabetes-Psychosis

1.107

0.008

3.025**

1.342–6.819

Diabetes-Cardiopathy

0.342

0.007

1.408**

1.098–1.806

Diabetes-Asthma

0.904

 < 0.001

2.469***

1.496–4.074

Diabetes-Hepatopathy

0.657

0.003

1.928**

1.256–2.959

Diabetes-Nephropathy

1.059

 < 0.001

2.882***

2.017–4.119

Diabetes-Arthritis

0.573

 < 0.001

1.774***

1.443–2.180

Diabetes-Disability

0.829

 < 0.001

2.291***

1.845–2.843

Diabetes-Cancer

0.839

0.024

2.314*

1.115–4.802

Hypertension-Apoplexy

0.583

 < 0.001

1.792***

1.323–2.426

Hypertension-Memory disorders

0.950

 < 0.001

2.585***

1.718–3.889

Hypertension-Psychosis

0.772

0.007

2.164**

1.241–3.775

Hypertension-Cardiopathy

0.422

 < 0.001

1.525***

1.316–1.767

Hypertension-Asthma

0.689

 < 0.001

1.992***

1.491–2.660

Hypertension-Hepatopathy

0.446

0.001

1.562**

1.189–2.054

Hypertension-Nephropathy

0.872

 < 0.001

2.393***

1.920–2.982

Hypertension-Arthritis

0.645

 < 0.001

1.906***

1.686–2.153

Hypertension-Disability

0.766

 < 0.001

2.151***

1.883–2.457

Hypertension-Cancer

0.710

0.005

2.035**

1.244–3.330

Apoplexy-Memory disorders

0.953

0.007

2.595**

1.306–5.156

Apoplexy-Psychosis

0.544

0.417

1.723

0.462–6.423

Apoplexy-Cardiopathy

0.730

0.001

2.075**

1.363–3.160

Apoplexy-Asthma

1.782

0.002

5.942**

1.890–18.677

Apoplexy-Hepatopathy

0.844

0.029

2.326*

1.092–4.955

Apoplexy-Nephropathy

1.094

 < 0.001

2.986***

1.761–5.062

Apoplexy-Arthritis

0.722

 < 0.001

2.059***

1.470–2.885

Apoplexy-Disability

0.746

 < 0.001

2.108***

1.542–2.882

Apoplexy-Cancer

1.866

0.106

6.465

0.672–62.183

Memory disorders-Psychosis

1.869

0.001

6.484**

2.089–20.124

Memory disorders-Cardiopathy

0.935

 < 0.001

2.547***

1.618–4.008

Memory disorders-Asthma

1.782

0.002

5.942**

1.890–18.677

Memory disorders-Hepatopathy

1.222

0.012

3.393*

1.314–8.764

Memory disorders-Nephropathy

1.515

 < 0.001

4.550***

2.140–9.676

Memory disorders-Arthritis

1.416

 < 0.001

4.120***

2.693–6.301

Memory disorders-Disability

1.139

 < 0.001

3.125***

2.185–4.469

Memory disorders-Cancer

0.767

0.443

2.154

0.303–15.299

Psychosis-Cardiopathy

1.502

 < 0.001

4.491***

2.420–8.334

Psychosis-Asthma

1.974

0.003

7.200**

1.980–26.185

Psychosis-Hepatopathy

1.870

 < 0.001

6.491***

2.356–17.878

Psychosis-Nephropathy

1.935

 < 0.001

6.926***

2.535–18.926

Psychosis-Arthritis

1.219

 < 0.001

3.382***

2.116–5.407

Psychosis-Disability

0.947

 < 0.001

2.577***

1.669–3.979

Psychosis-Cancer

21.972

0.999

3.4*109

0-∞

Cardiopathy-Asthma

0.860

 < 0.001

2.363***

1.730–3.227

Cardiopathy-Hepatopathy

0.595

 < 0.001

1.813***

1.350–2.435

Cardiopathy-Nephropathy

0.949

 < 0.001

2.584***

2.026–3.295

Cardiopathy-Arthritis

0.777

 < 0.001

2.174***

1.873–2.524

Cardiopathy-Disability

0.771

 < 0.001

2.161***

1.830–2.553

Cardiopathy-Cancer

0.731

0.011

2.077*

1.184–3.643

Asthma-Hepatopathy

0.005

0.988

1.005

0.532–1.898

Asthma-Nephropathy

0.876

 < 0.001

2.402***

1.545–3.735

Asthma-Arthritis

0.853

 < 0.001

2.346***

1.814–3.034

Asthma-Disability

0.800

 < 0.001

2.225***

1.704–2.906

Asthma-Cancer

0.923

0.098

2.516

0.845–7.494

Hepatopathy-Nephropathy

0.955

 < 0.001

2.598***

1.831–3.685

Hepatopathy-Arthritis

0.707

 < 0.001

2.027***

1.605–2.560

Hepatopathy-Disability

0.798

 < 0.001

2.222***

1.679–2.942

Hepatopathy-Cancer

1.330

0.003

3.783**

1.585–9.028

Nephropathy-Arthritis

0.939

 < 0.001

2.557***

2.131–3.067

Nephropathy-Disability

1.515

 < 0.001

4.550***

2.140–9.676

Nephropathy-Cancer

0.695

0.072

2.004

0.941–4.270

Arthritis-Disability

0.948

 < 0.001

2.579***

2.290–2.905

Arthritis-Cancer

1.065

 < 0.001

2.900***

1.802–4.666

Disability-Cancer

0.706

 < 0.001

2.026***

1.218–3.368

  1. *P < 0.05, **P < 0.01, ***P < 0.001.
  2. Significant values are in bold.
Back to article page